CCIA
COLL icon

Campbell & Co Investment Adviser’s Collegium Pharmaceutical COLL Stock Holding History

Campbell & Co Investment Adviser’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Sell
6,753
-66,480
-91% -$2.27M 0.01% 949
2026
Q1 		$2.42M Buy
73,233
+33,195
+83% +$1.41M 0.14% 224
2025
Q4 		$1.85M Buy
40,038
+20,831
+108% +$872K 0.09% 352
2025
Q3 		$672K Sell
19,207
-19,545
-50% -$679K 0.05% 590
2025
Q2 		$1.15M Sell
38,752
-8,816
-19% -$251K 0.07% 450
2025
Q1 		$1.42M Buy
+47,568
New +$1.45M 0.11% 294
2024
Q3 		– Sell
-41,704
Closed -$1.34M – 1127
2024
Q2 		$1.34M Buy
+41,704
New +$1.45M 0.11% 262
2023
Q4 		– Sell
-12,871
Closed -$288K – 1130
2023
Q3 		$288K Buy
+12,871
New +$294K 0.03% 735
2023
Q2 		– Sell
-68,138
Closed -$1.63M – 921
2023
Q1 		$1.63M Buy
68,138
+57,544
+543% +$1.53M 0.3% 47
2022
Q4 		$246K Sell
10,594
-861
-8% -$17.4K 0.06% 618
2022
Q3 		$184K Buy
+11,455
New +$202K 0.04% 630
2022
Q2 		– Sell
-51,753
Closed -$1.05M – 709
2022
Q1 		$1.05M Buy
51,753
+41,753
+418% +$789K 0.28% 72
2021
Q4 		$187K Buy
+10,000
New +$195K 0.06% 544
2020
Q3 		– Sell
-11,855
Closed -$207K – 392
2020
Q2 		$207K Buy
+11,855
New +$232K 0.26% 212
2020
Q1 		– Sell
-11,875
Closed -$244K – 123
2019
Q4 		$244K Buy
11,875
+1,764
+17% +$29.4K 0.07% 503
2019
Q3 		$116K Buy
+10,111
New +$115K 0.04% 572

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Campbell & Co Investment Adviser's COLL Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Collegium Pharmaceutical (COLL) stake by 91% in Q2 2026, selling an estimated $2.27M and leaving 6,753 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #949.

Campbell & Co Investment Adviser first reported a position in COLL in Q3 2019 and has held it in 16 quarters since. The position peaked at $2.42M in Q1 2026. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Campbell & Co Investment Adviser held 6,753 shares of Collegium Pharmaceutical worth $244K as of Q2 2026.
  • Campbell & Co Investment Adviser sold 66,480 Collegium Pharmaceutical shares in Q2 2026, an estimated $2.27M.
  • Collegium Pharmaceutical made up 0.01% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #949 holding.
  • Campbell & Co Investment Adviser first reported a position in Collegium Pharmaceutical in Q3 2019 and has held it in 16 quarters since.
  • Campbell & Co Investment Adviser's Collegium Pharmaceutical position peaked at $2.42M in Q1 2026.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.